From drift to decision-making, why must European Union testing and regulatory frameworks evolve alongside application technology?
Speed has become the currency of SaaS businesses. New features are expected faster, releases happen more frequently, and customers have little patience for glitches or...Read More The post SaaS ...
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...
Effect of intervention on a quality measure of pain management at Medstar Washington Cancer Institute. This is an ASCO Meeting Abstract from the 2014 Quality Care Symposium. This abstract does not ...
Because electronic systems for all applications in end-user markets must provide the highest possible reliability to match customers’ quality expectations, semiconductor components undergo multiple ...
FDA and NIH recently announced initiatives outlining specific actions each agency will take to encourage greater adoption of new and emerging technologies to reduce the need for — and potentially ...